Atrial Fibrillation During or After TAVI: Incidence, Implications and Therapeutical Considerations

201622 citationsReview

Authors

Μanolis Vavuranakis · Synelixis (Greece)

Angelos‐Michail Kolokathis

Dimitrios A. Vrachatis

Konstantinos Kalogeras

Abstract

Limited data are available regarding the optimal therapeutic regimen in patients undergoing TAVI who need therapy for AF. Carefully designed clinical studies might further clarify the incidence and interrelation between atrial fibrillation and TAVI. The balance between the efficacy and risk of anticoagulation needs to be further clarified in patients undergoing TAVI.

Topics & Keywords

Atrial Fibrillation Management and Outcomes Cardiac Valve Diseases and Treatments Cardiac pacing and defibrillation studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Current Pharmaceutical Design

Volume 22, Issue 13, pp. 1896-1903

DOI: 10.2174/1381612822666151208123050

Field-Weighted Citation Impact: 2.64